These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 1677177)
1. Serum tumor necrosis factor alpha, interleukin 1-beta, p24 antigen concentrations and CD4+ cells at various stages of human immunodeficiency virus 1 infection in children. Arditi M; Kabat W; Yogev R Pediatr Infect Dis J; 1991 Jun; 10(6):450-5. PubMed ID: 1677177 [TBL] [Abstract][Full Text] [Related]
2. Serum levels of IL-2, IL-1 alpha, TNF-alpha, and soluble receptor of IL-2 in HIV-1-infected patients. Scott-Algara D; Vuillier F; Marasescu M; de Saint Martin J; Dighiero G AIDS Res Hum Retroviruses; 1991 Apr; 7(4):381-6. PubMed ID: 1676897 [TBL] [Abstract][Full Text] [Related]
3. CD4 lymphocyte counts and serum p24 antigen of no diagnostic value in monitoring HIV-infected patients with pulmonary symptoms. Orholm M; Nielsen TL; Nielsen JO; Lundgren JD AIDS; 1990 Feb; 4(2):163-6. PubMed ID: 1970256 [TBL] [Abstract][Full Text] [Related]
4. Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Evidence for a bimodal expression of clinical and biological symptoms. Blanche S; Tardieu M; Duliege A; Rouzioux C; Le Deist F; Fukunaga K; Caniglia M; Jacomet C; Messiah A; Griscelli C Am J Dis Child; 1990 Nov; 144(11):1210-5. PubMed ID: 1978551 [TBL] [Abstract][Full Text] [Related]
5. Quantitation of human immunodeficiency virus in vertically infected infants and children. Alimenti A; Luzuriaga K; Stechenberg B; Sullivan JL J Pediatr; 1991 Aug; 119(2):225-9. PubMed ID: 1677684 [TBL] [Abstract][Full Text] [Related]
6. Correlation of serum antigen and antibody concentration with clinical features in HIV infection. Ellaurie M; Rubinstein A Arch Dis Child; 1991 Feb; 66(2):200-3. PubMed ID: 1705767 [TBL] [Abstract][Full Text] [Related]
7. Deficient human immunodeficiency virus type 1-specific cytotoxic T cell responses in vertically infected children. Luzuriaga K; Koup RA; Pikora CA; Brettler DB; Sullivan JL J Pediatr; 1991 Aug; 119(2):230-6. PubMed ID: 1907319 [TBL] [Abstract][Full Text] [Related]
8. Interferon-alpha and tumor necrosis factor-alpha in serum of patients in various stages of HIV-1 infection. von Sydow M; Sönnerborg A; Gaines H; StrannegÄrd O AIDS Res Hum Retroviruses; 1991 Apr; 7(4):375-80. PubMed ID: 1906289 [TBL] [Abstract][Full Text] [Related]
9. Immune activation markers and AIDS prognosis. Osmond DH; Shiboski S; Bacchetti P; Winger EE; Moss AR AIDS; 1991 May; 5(5):505-11. PubMed ID: 1677808 [TBL] [Abstract][Full Text] [Related]
10. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191 [TBL] [Abstract][Full Text] [Related]
11. Effect of azidothymidine (AZT) on HIV P24 antigen, beta 2-microglobulin, neopterin, soluble CD8, soluble interleukin-2 receptor and tumor necrosis factor alpha levels in patients with AIDS-related complex or AIDS. Reddy MM; McKinley G; Englard A; Grieco MH Int J Immunopharmacol; 1990; 12(7):737-41. PubMed ID: 2127261 [TBL] [Abstract][Full Text] [Related]
12. High-level viremia in adults and children infected with human immunodeficiency virus: relation to disease stage and CD4+ lymphocyte levels. Saag MS; Crain MJ; Decker WD; Campbell-Hill S; Robinson S; Brown WE; Leuther M; Whitley RJ; Hahn BH; Shaw GM J Infect Dis; 1991 Jul; 164(1):72-80. PubMed ID: 1676046 [TBL] [Abstract][Full Text] [Related]
13. Polyfunctional CD4(+) T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine. Van Braeckel E; Desombere I; Clement F; Vandekerckhove L; Verhofstede C; Vogelaers D; Leroux-Roels G Vaccine; 2013 Aug; 31(36):3739-46. PubMed ID: 23707169 [TBL] [Abstract][Full Text] [Related]
14. Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial. Lane HC; Davey V; Kovacs JA; Feinberg J; Metcalf JA; Herpin B; Walker R; Deyton L; Davey RT; Falloon J Ann Intern Med; 1990 Jun; 112(11):805-11. PubMed ID: 1971503 [TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha in pediatric HIV-1 infection. Ellaurie M; Rubinstein A AIDS; 1992 Nov; 6(11):1265-8. PubMed ID: 1472332 [TBL] [Abstract][Full Text] [Related]
16. Surrogate markers for AIDS treatment. Jacobson M Nurs Times; 1991 May 29-Jun 4; 87(22):49. PubMed ID: 1675013 [No Abstract] [Full Text] [Related]
17. Progressive and selective impairment of IL-3 and IL-4 production by peripheral blood CD4+ T-lymphocytes during the course of HIV-1 infection. Re MC; Zauli G; Furlini G; Ranieri S; La Placa M Viral Immunol; 1992; 5(3):185-94. PubMed ID: 1358089 [TBL] [Abstract][Full Text] [Related]
18. T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+ lymphocyte count in non-progressors and progressors towards AIDS. Levacher M; Tallet S; Dazza MC; Dournon E; Rouveix B; Pocidalo JJ Clin Exp Immunol; 1990 Aug; 81(2):177-82. PubMed ID: 1696859 [TBL] [Abstract][Full Text] [Related]
19. Circulating human immunodeficiency virus (HIV) p24 antigen-positive lymphocytes: a flow cytometric measure of HIV infection. Ohlsson-Wilhelm BM; Cory JM; Kessler HA; Eyster ME; Rapp F; Landay A J Infect Dis; 1990 Nov; 162(5):1018-24. PubMed ID: 1977803 [TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor and HIV P24 antigen levels in serum of HIV-infected populations. Reddy MM; Sorrell SJ; Lange M; Grieco MH J Acquir Immune Defic Syndr (1988); 1988; 1(5):436-40. PubMed ID: 3146635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]